What is Crinetics Pharmaceuticals Inc (CRNX)?
Crinetics Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of novel therapeutics targeting endocrine-related disorders. The company focuses on advancing treatments for rare and chronic diseases through innovative drug candidates. Crinetics Pharmaceuticals conducts research and clinical development programs aimed at addressing unmet medical needs. Its pipeline includes compounds designed to modulate hormone receptors and related biological pathways. The company collaborates with research institutions and regulatory agencies to support drug development and approval processes. Crinetics Pharmaceuticals operates under the regulatory standards governing pharmaceutical research and development.
Crinetics Pharmaceuticals Inc Stock Price Today: Live Overview
The price today is shaped by current session trading for Crinetics Pharmaceuticals Inc, at $35.62. Price levels have ranged from $35.09 to $35.87 during the day, showing a daily change of 0%.
FAQ: Crinetics Pharmaceuticals Inc (CRNX)
What is the current price of CRNX stock?
Crinetics Pharmaceuticals Inc closed at $35.62.
Does CRNX pay dividends?
Crinetics Pharmaceuticals Inc does not pay dividends.
Does CRNX have a formal corporate presence or regional headquarters in the UAE?
Crinetics Pharmaceuticals Inc does not have an official office or subsidiary in the UAE and operates primarily in the US.
What is CRNX best known for?
The company is most famous for developing treatments for rare endocrine diseases.
What assets are typically shown together with CRNX?
Commonly shown alongside CRNX: Invivyd Inc., Replimune, Clene Inc.
Latest shares articles



